# The Effect of Medication Timing on Anticoagulation Stability in Users of Warfarin: The "INRange" RCT

> **NCT02376803** · PHASE4 · COMPLETED · sponsor: **University of Alberta** · enrollment: 217 (actual)

## Conditions studied

- Atrial Fibrillation
- Thrombus Due to Heart Valve Prosthesis
- Deep Venous Thrombosis
- Thromboembolism
- DVT

## Interventions

- **DRUG:** Warfarin

## Key facts

- **NCT ID:** NCT02376803
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2016-09-30
- **Final completion:** 2018-04-27
- **Target enrollment:** 217 (ACTUAL)
- **Last updated:** 2018-05-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02376803

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02376803, "The Effect of Medication Timing on Anticoagulation Stability in Users of Warfarin: The "INRange" RCT". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02376803. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*